SeaStar MEdical Holdings Publishes Manuscript On Multiorgan Failure Patients Treated With Selective Cytopheretic Device
SeaStar MEdical Holdings Publishes Manuscript On Multiorgan Failure Patients Treated With Selective Cytopheretic Device
SeaStar MediCal Holdings發佈了關於使用選擇性細胞移植設備治療的多器官衰竭患者的手稿
SCD's ability to improve clinical status of four critically ill pediatric and adult patients across multiple clinical conditions published in Transplantation Direct
SCD改善四名患有多種臨床疾病的危重兒科和成人患者的臨床狀況的能力，發表在《移植指南》上
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。